Separating instability from aggregation propensity in γS-crystallin variants

Biophysical Journal

Volumn 100, Issue 2, 2011, Pages 498-506

  Brubaker, William D ^a   Freites, J Alfredo ^b   Golchert, Kory J ^b   Shapiro, Rebecca A ^b   Morikis, Vasilios ^b   Tobias, Douglas J ^b   Martin, Rachel W ^a,b  

^a Department of Molecular Biology and Biochemistry ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78751691643     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.12.3691     Document Type: Article

References (67)

1. Chiti, F., and C. M. Dobson. 2006. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75:333-366.
2. Booth, D. R., M. Sunde,..., M. B. Pepys. 1997. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature. 385:787-793.
3. Pepys, M. B., P. N. Hawkins,..., J. J. Hsuan. 1993. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature. 362:553-557.
4. Liemann, S., and R. Glockshuber. 1999. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry. 38:3258-3267.
5. Caughey, B., and P. T. Lansbury. 2003. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26:267-298.
6. Hosszu, L. L. P., G. S. Jackson,..., J. Collinge. 2004. The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC. J. Biol. Chem. 279:28515-28521.
7. Bae, S.-H., G. Legname,..., H. J. Dyson. 2009. Prion proteins with pathogenic and protective mutations show similar structure and dynamics. Biochemistry. 48:8120-8128.
8. Sinha, N., C. Tsai, and R. Nussinov. 2001. A proposed structural model for amyloid fibril elongation: domain swapping forms an interdigitating β-structure polymer. Protein Eng. 14:93-103.
9. Liu, Y., G. Gotte,..., D. Eisenberg. 2001. A domain-swapped RNase A dimer with implications for amyloid formation. Nat. Struct. Biol. 8:211-214.
10. Sanders, A., C. Jeremy Craven,..., R. A. Staniforth. 2004. Cystatin forms a tetramer through structural rearrangement of domain-swapped dimers prior to amyloidogenesis. J. Mol. Biol. 336:165-178.
11. Chow, M. K., A. M. Ellisdon,..., S. P. Bottomley. 2004. Polyglutamine expansion in ataxin-3 does not affect protein stability: implications for misfolding and disease. J. Biol. Chem. 279:47643-47651.
12. Eakin, C. M., F. J. Attenello,..., A. D. Miranker. 2004. Oligomeric assembly of native-like precursors precedes amyloid formation by β-2 microglobulin. Biochemistry. 43:7808-7815.
13. Chiti, F., and C. M. Dobson. 2009. Amyloid formation by globular proteins under native conditions. Nat. Chem. Biol. 5:15-22.
14. Mukherjee, S., P. Chowdhury, and F. Gai. 2009. Effect of dehydration on the aggregation kinetics of two amyloid peptides. J. Phys. Chem. B. 113:531-535.
15. Kim, Y. S., L. Liu,..., R. M. Hochstrasser. 2009. 2D IR provides evidence for mobile water molecules in β-amyloid fibrils. Proc. Natl. Acad. Sci. USA. 106:17751-17756.
16. Hamley, I. W., D. R. Nutt,..., F. Rodríguez-Llansola. 2010. Influence of the solvent on the self-assembly of a modified amyloid β peptide fragment. II. NMR and computer simulation investigation. J. Phys. Chem. B. 114:940-951.
17. Horwitz, J. 1992. α-Crystallin can function as a molecular chaperone. Proc. Natl. Acad. Sci. USA. 89:10449-10453.
18. Tanaka, N., R. Tanaka,..., D. Hamada. 2008. Amyloid fibril formation and chaperone-like activity of peptides from αA-crystallin. Biochemistry. 47:2961-2967.
19. Wenk, M., R. Herbst,..., R. Jaenicke. 2000. γS-crystallin of bovine and human eye lens: solution structure, stability and folding of the intact two-domain protein and its separate domains. Biophys. Chem. 86:95-108.
20. Mills, I. A., S. L. Flaugh,..., J. A. King. 2007. Folding and stability of the isolated Greek key domains of the long-lived human lens proteins γD-crystallin and γS-crystallin. Protein Sci. 16:2427-2444.
21. Delaye, M., and A. Tardieu. 1983. Short-range order of crystallin proteins accounts for eye lens transparency. Nature. 302:415-417.
22. Tardieu, A., F. Vérétout,..., C. Slingsby. 1992. Protein interactions in the calf eye lens: interactions between β-crystallins are repulsive whereas in γ-crystallins they are attractive. Eur. Biophys. J. 21:1-12.
23. Papanikolopoulou, K., I. Mills-Henry,..., J. King. 2008. Formation of amyloid fibrils in vitro by human γD-crystallin and its isolated domains. Mol. Vis. 14:81-89.
24. Wang, Y., S. Petty,..., J. King. 2010. Formation of amyloid fibrils in vitro from partially unfolded intermediates of human γC-crystallin. Invest. Ophthalmol. Vis. Sci. 51:672-678.
25. Takemoto, L., A. Ponce, and C. M. Sorensen. 2008. Age-dependent association of γ-crystallins with aged α-crystallins from old bovine lens. Mol. Vis. 14:970-974.
26. Diaz-Avalos, R., C. Long,..., D. L. Caspar. 2003. Cross-β order and diversity in nanocrystals of an amyloid-forming peptide. J. Mol. Biol. 330:1165-1175.
27. Sawaya, M. R., S. Sambashivan,..., D. Eisenberg. 2007. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature. 447:453-457.
28. Ferguson, N., J. Becker,..., A. R. Fersht. 2006. General structural motifs of amyloid protofilaments. Proc. Natl. Acad. Sci. USA. 103:16248-16253.
29. Petkova, A. T., W. M. Yau, and R. Tycko. 2006. Experimental constraints on quaternary structure in Alzheimer's β-amyloid fibrils. Biochemistry. 45:498-512.
30. Heise, H. 2008. Solid-state NMR spectroscopy of amyloid proteins. Chem Bio Chem. 9:179-189.
31. Paravastu, A. K., I. Qahwash,..., R. Tycko. 2009. Seeded growth of bamyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc. Natl. Acad. Sci. USA. 106:7443-7448.
32. Strasfeld, D. B., Y. L. Ling,..., M. T. Zanni. 2009. Strategies for extracting structural information from 2D IR spectroscopy of amyloid: application to islet amyloid polypeptide. J. Phys. Chem. B. 113:15679-15691.
33. Popova, L. A., R. Kodali,..., I. K. Lednev. 2010. Structural variations in the cross-β core of amyloid β fibrils revealed by deep UV resonance Raman spectroscopy. J. Am. Chem. Soc. 132:6324-6328.
34. Purkiss, A. G., O. A. Bateman,..., C. Slingsby. 2002. The X-ray crystal structure of human γS-crystallin C-terminal domain. J. Biol. Chem. 277:4199-4205.
35. Wu, Z., F. Delaglio,..., A. Bax. 2005. Solution structure of (γ) S-crystallin by molecular fragment replacement NMR. Protein Sci. 14:3101-3114.
36. Litt, M., P. Kramer,..., R. G. Weleber. 1998. Autosomal dominant congenital cataract associated with a missense mutation in the human a crystallin gene CRYAA. Hum. Mol. Genet. 7:471-474.
37. Liu, Y. Z., X. Y. Zhang,..., F. Shang. 2006. A novel αB-crystallin mutation associated with autosomal dominant congenital lamellar cataract. Invest. Ophthalmol. Vis. Sci. 47:1069-1075.
38. Litt, M., R. Carrero-Valenzuela,..., I. H. Maumenee. 1997. Autosomal dominant cerulean cataract is associated with a chain termination mutation in the human β-crystallin gene CRYBB2. Hum. Mol. Genet. 6:665-668.
39. Sun, H., Z. Ma,..., Y. Shen. 2005. γ-S crystallin gene (CRYGS) mutation causes dominant progressive cortical cataract in humans. J. Med. Genet. 42:706-710.
40. Li, F. F., S. Z. Wang,..., X. Ma. 2008. Mutation G61C in the CRYGD gene causing autosomal dominant congenital coralliform cataracts. Mol. Vis. 14:378-386.
41. Basak, A., O. Bateman,..., J. Pande. 2003. High-resolution X-ray crystal structures of human γD crystallin (1.25 A) and the R58H mutant (1.15 A) associated with aculeiform cataract. J. Mol. Biol. 328:1137-1147.
42. Pande, A., J. Pande,..., G. B. Benedek. 2001. Crystal cataracts: human genetic cataract caused by protein crystallization. Proc. Natl. Acad. Sci. USA. 98:6116-6120.
43. Pande, A., O. Annunziata,..., J. Pande. 2005. Decrease in protein solubility and cataract formation caused by the Pro23 to Thr mutation in human γ D-crystallin. Biochemistry. 44:2491-2500.
44. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
45. Pauling, L., H. A. Itano,..., I. C. Wells. 1949. Sickle cell anemia a molecular disease. Science. 110:543-548.
46. Pan, W., O. Galkin,..., P. G. Vekilov. 2007. Metastable mesoscopic clusters in solutions of sickle-cell hemoglobin. Biophys. J. 92:267-277. (Pubitemid 46048434)
47. Pan, W., P. G. Vekilov, and V. Lubchenko. 2010. Origin of anomalous mesoscopic phases in protein solutions. J. Phys. Chem. B. 114:7620-7630.
48. Ma, Z., G. Piszczek,..., J. F. Hejtmancik. 2009. The G18V CRYGS mutation associated with human cataracts increases 7gamma;S-crystallin sensitivity to thermal and chemical stress. Biochemistry. 48:7334-7341.
49. Guex, N., and M. C. Peitsch. 1997. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 18:2714-2723.
50. Kale, L., R. Skeel,..., K. Schulten. 1999. NAMD2: greater scalability for parallel molecular dynamics. J. Comput. Phys. 151:283-312.
51. MacKerell, Jr., A. D., D. Bashford., M. Karplus. 1998. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B. 102:3586-3616.
52. Jorgensen, W., J. Chandrasekhar,..., M. Klein. 1983. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79:926.
53. Essmann, U., L. Perera,..., L. G. Pedersen. 1995. A smooth particle mesh Ewald method. J. Chem. Phys. 103:8577-8593.
54. Batcho, P. F., D. A. Case, and T. Schlick. 2001. Optimized particlemesh Ewald/multiple-time step integration for molecular dynamics simulations. J. Chem. Phys. 115:4003-4018.
55. Grubmuller, H., H. Heller,..., K. Schulten. 1991. Generalized Verlet algorithm for efficient molecular dynamics simulations with longrange interactions. Mol. Simul. 6:121-142.
56. Feller, S. E., Y. Zhang,..., B. R. Brooks. 1995. Constant-pressure molecular-dynamics simulation-the Langevin piston method. J. Chem. Phys. 103:4613-4621.
57. Martyna, G. J., D. J. Tobias, and M. L. Klein. 1994. Constant-pressure molecular-dynamics algorithms. J. Chem. Phys. 101:4177-4189.
58. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molecular dynamics. J. Mol. Graph. 14:33-38, 27-28.
59. Pettersen, E. F., T. D. Goddard,..., T. E. Ferrin. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612.
60. R Development Core Team. 2008. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org.
61. Grant, B. J., A. P. C. Rodrigues,..., L. S. Caves. 2006. Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics. 22:2695-2696.
62. Chen, J., P. R. Callis, and J. King. 2009. Mechanism of the very efficient quenching of tryptophan fluorescence in human γD-and γS-crystallins: the γ-crystallin fold may have evolved to protect tryptophan residues from ultraviolet photodamage. Biochemistry. 48:3708-3716.
63. Xu, J., J. Chen,..., J. R. Knutson. 2009. Femtosecond fluorescence spectra of tryptophan in human γ-crystallin mutants: site-dependent ultrafast quenching. J. Am. Chem. Soc. 131:16751-16757.
64. Hardy, J., and D. J. Selkoe. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297:353-356.
65. Paliwal, A., D. Asthagiri,..., M. E. Paulaitis. 2005. Light-scattering studies of protein solutions: role of hydration in weak protein-protein interactions. Biophys. J. 89:1564-1573.
66. Rasaiah, J. C., S. Garde, and G. Hummer. 2008. Water in nonpolar confinement: from nanotubes to proteins and beyond. Annu. Rev. Phys. Chem. 59:713-740.
67. Padrick, S. B., and A. D. Miranker. 2002. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry. 41:4694-4703.